BRIEF-U.S. FDA says approved Abbvie's Mavyret for Hepatitis C
August 03, 2017 at 15:22 PM EDT
* U.S. FDA- FDA granted the application priority review, breakthrough therapy designations, granted approval of Mavyret to Abbvie Inc Source text : (http://bit.ly/2vxrKo3) Further company coverage:
